相关实验视频
Updated: Jul 23, 2025

23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
8.0K
帕金森病:生命末期的症状和药物治疗
Elisabeth Alice Wilson1, Emily King-Oakley2, Edward William Richfield2
1Medicine for Older People, North Bristol NHS Trust, Bristol, UK ewilson22@nhs.net.
BMJ supportive & palliative care
|July 18, 2023
概括
患有帕金森病的人在生命末期经历了显著的动荡和疼痛. 认知障碍增加了动荡风险,趋向于更高的镇静剂量.
科学领域:
- 抚慰性护理是一种缓解性护理.
- 神经学 神经学
- 老年学是指老年学的学科.
背景情况:
- 帕金森病 (PwP) 呈现出相当大的息性症状负担,相当于晚期恶性瘤.
- 在PwP中了解生命终端 (EOL) 症状管理对于改善护理质量至关重要.
研究的目的:
- 调查帕金森病患者生命最后72小时的症状频率和药物治疗趋势.
- 确定影响症状负担和EOL帕金森病护理治疗的因素.
主要方法:
- 对2019年2月至2020年9月期间死亡的PwP医疗记录的回顾性审查.
- 分析死亡前72小时的症状记录和处方药物的分析.
主要成果:
- 激动 (60.78%) 和疼痛 (58.82%) 是最后72小时最常见的症状.
- 认知障碍与4.67倍的兴奋和更高的米达佐拉姆剂量增加的可能性有关.
- 末端运动症状不常见;只有28.57%的患者使用了推剂量的罗提古丁.
结论:
- 帕金森病患者在EOL时面临着显著的症状负担,其动荡率与一般人群相似.
- 镇静,而不是止痛,在认知障碍患者中倾向于使用更高的剂量.
- 末端硬是罕见但重要的症状;需要对EOL罗提古丁使用进行进一步的研究.
相关概念视频
Parkinson's Disease: Treatment
301
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
301
Parkinson's Disease: Overview
601
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
601
Alzheimer's Disease: Treatment
219
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
219
Antipsychotic Drugs: Therapeutic Uses and Side Effects
266
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
266
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
COPD: Pathogenesis and Clinical Features
354
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
354

